Skip to main content
Clinical Trials/NCT00912028
NCT00912028
Completed
Not Applicable

Multicenter, Single-masked, Randomized, Parallel, Controlled Study to Compare Senofilcon A Contact Lenses to Currently Used Contact Lenses

Johnson & Johnson Vision Care, Inc.0 sites71 target enrollmentMay 1, 2009
ConditionsMyopia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopia
Sponsor
Johnson & Johnson Vision Care, Inc.
Enrollment
71
Primary Endpoint
Limbal Hyperemia (Redness)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of the study is to evaluate the possible benefits of second generation silicone hydrogel contact lenses.

Registry
clinicaltrials.gov
Start Date
May 1, 2009
End Date
February 1, 2010
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects must:
  • be existing soft contact lens wearers of the study control lenses
  • require a distance visual correction in both eyes
  • have a contact lens spherical distance requirement between -1.00 diopters (D) and -8.00D in both eyes
  • have astigmatism less than or equal to 1.00D in both eyes
  • be able to wear lenses available for this study
  • be corrected to a visual acuity of 6/9 (20/30) or better in each eye
  • have normal eyes with no evidence of abnormality or disease

Exclusion Criteria

  • Subject are excluded for the following reasons:
  • monovision corrected
  • worn lenses extended wear in the last 3 months.
  • require concurrent ocular medication
  • grade 3 or 4 abnormalities
  • grade 3 corneal staining in more than two regions
  • anterior ocular surgery
  • any other ocular surgery or injury within 8 weeks prior to study enrollment
  • abnormal lachrymal secretions
  • pre-existing ocular irritation that would preclude contact lens fitting

Outcomes

Primary Outcomes

Limbal Hyperemia (Redness)

Time Frame: 4 weeks

Subject distribution according to limbal hyperemia scale in each eye during the 4-week Follow-up Visit. For this scale, 0 is lowest and 4 is greatest. If present in at least one eye, then it is counted.

Bulbar Hyperemia (Redness)

Time Frame: 4 weeks

Subject distribution according to bulbar hyperemia scale in each eye during the 4-week Follow-up Visit. For this scale, 0 is lowest and 4 is greatest. If present in at least one eye, then it is counted.

Corneal Staining

Time Frame: 4 weeks

Subject distribution according to corneal staining with fluorescein scale in each eye during the 4-week Follow-up Visit. For this scale, 0 is lowest and 4 is greatest. If present in at least one eye, then it is counted.

Similar Trials